Published in Blood on February 26, 2004
B cells "transduced" with TAT-fusion proteins can induce tolerance and protect mice from diabetes and EAE. Clin Immunol (2011) 1.44
B-Cell Gene Therapy for Tolerance Induction: Host but Not Donor B-Cell Derived IL-10 is Necessary for Tolerance. Front Microbiol (2011) 0.90
Reprogrammed quiescent B cells provide an effective cellular therapy against chronic experimental autoimmune encephalomyelitis. Eur J Immunol (2011) 0.85
B-cell delivered gene therapy for tolerance induction: role of autoantigen-specific B cells. J Autoimmun (2010) 0.84
Anergy in memory CD4+ T cells is induced by B cells. J Immunol (2008) 0.83
Tolerance induction in experimental autoimmune encephalomyelitis using non-myeloablative hematopoietic gene therapy with autoantigen. Mol Ther (2009) 0.79
Peripheral CD4(+) T-cell tolerance is induced in vivo by rare antigen-bearing B cells in follicular, marginal zone, and B-1 subsets. Eur J Immunol (2013) 0.77
Aspergillus fumigatus triggers inflammatory responses by stage-specific beta-glucan display. PLoS Pathog (2005) 3.01
Inflammatory monocytes facilitate adaptive CD4 T cell responses during respiratory fungal infection. Cell Host Microbe (2009) 2.81
Human immunodeficiency virus type 1 recombination: rate, fidelity, and putative hot spots. J Virol (2002) 2.50
A newly discovered function for RNase L in regulating translation termination. Nat Struct Mol Biol (2005) 1.80
Short communication: activation of latent HIV type 1 gene expression by suberoylanilide hydroxamic acid (SAHA), an HDAC inhibitor approved for use to treat cutaneous T cell lymphoma. AIDS Res Hum Retroviruses (2009) 1.66
Global analysis of Pub1p targets reveals a coordinate control of gene expression through modulation of binding and stability. Mol Cell Biol (2005) 1.50
The human immunodeficiency virus type 1 ribosomal frameshifting site is an invariant sequence determinant and an important target for antiviral therapy. J Virol (2004) 1.27
Immunity to fungi. Curr Opin Immunol (2006) 1.24
Innate recognition of cell wall β-glucans drives invariant natural killer T cell responses against fungi. Cell Host Microbe (2011) 1.18
Regulation of gene expression in experimental autoimmune encephalomyelitis indicates early neuronal dysfunction. Brain (2003) 1.10
Immune responses against Aspergillus fumigatus: what have we learned? Curr Opin Infect Dis (2011) 1.09
Mutational analysis of HIV-1 long terminal repeats to explore the relative contribution of reverse transcriptase and RNA polymerase II to viral mutagenesis. J Biol Chem (2002) 1.09
High rate of genetic recombination in murine leukemia virus: implications for influencing proviral ploidy. J Virol (2006) 1.08
Repopulation of rat liver by fetal hepatoblasts and adult hepatocytes transduced ex vivo with lentiviral vectors. Hepatology (2003) 1.00
Pharmaceutical therapies to recode nonsense mutations in inherited diseases. Pharmacol Ther (2012) 1.00
High-throughput screening uncovers a compound that activates latent HIV-1 and acts cooperatively with a histone deacetylase (HDAC) inhibitor. J Biol Chem (2011) 0.97
Human immunodeficiency virus type 1 latency model for high-throughput screening. Antimicrob Agents Chemother (2005) 0.94
Plasma osteopontin modulates chronic restraint stress-induced thymus atrophy by regulating stress hormones: inhibition by an anti-osteopontin monoclonal antibody. J Immunol (2009) 0.91
Cytokines and the regulation of fungus-specific CD4 T cell differentiation. Cytokine (2011) 0.90
Defective ubiquitin-mediated degradation of antiapoptotic Bfl-1 predisposes to lymphoma. Blood (2010) 0.89
Toward the development of a virus-cell-based assay for the discovery of novel compounds against human immunodeficiency virus type 1. Antimicrob Agents Chemother (2003) 0.83
A HIV-2-based self-inactivating vector for enhanced gene transduction. J Biotechnol (2006) 0.83
Proteasome inhibitors act as bifunctional antagonists of human immunodeficiency virus type 1 latency and replication. Retrovirology (2013) 0.82
In vivo post-transcriptional regulation of CD154 in mouse CD4+ T cells. Eur J Immunol (2009) 0.81
Efficient co-expression of bicistronic proteins in mesenchymal stem cells by development and optimization of a multifunctional plasmid. Stem Cell Res Ther (2011) 0.80
The influence of follicular migration on T-cell differentiation. Immunology (2004) 0.79
Post-transcriptionally regulated expression system in human xenogeneic transplantation models. Mol Ther (2011) 0.78
Choice and use of appropriate packaging cell types. Methods Mol Biol (2003) 0.77
HIV type-1 latency: targeted induction of proviral reservoirs. Antivir Chem Chemother (2009) 0.77
Host stem cells can selectively reconstitute missing lymphoid lineages in irradiation bone marrow chimeras. Blood (2003) 0.77
Proviral progeny of heterodimeric virions reveal a high crossover rate for human immunodeficiency virus type 2. J Virol (2006) 0.77
IFN-γ signals a changing of the guards. Immunity (2012) 0.76
New strategies for immune-mediated anti-viral drug and vaccine development. Curr Pharm Des (2006) 0.75
Cross-reactive antibodies induced by xenogeneic IgA can cause selective IgA deficiency. Autoimmunity (2010) 0.75
Isolation of multilineage progenitors from mouse brain. In Vitro Cell Dev Biol Anim (2013) 0.75